Parallel-group controlled trial of esophagectomy versus chemoradiotherapy in patients with clinical stage I esophageal carcinoma (JCOG0502).
Ken Kato(National Cancer Center Hospital East), Yuko Kitagawa(Keio University), Masahiko Yano(Nagoya Sangyo University), Tetsuya Abe(Aichi Cancer Center), Hiroyasu Igaki(Apple (Israel)), Shigeru Tsunoda(Kyoto University), Junki Mizusawa(Japan Clinical Cancer Research Organization), Yasushi Toh(National Hospital Organization Kyushu Cancer Center), Satoru Nakagawa(Apple (Israel)), Isao Nozaki(National Hospital Organization), Hiroyuki Daiko(Juntendo University), Yoshinori Ito(National Cancer Center Hospital East), Hiroshi Katayama, Kenichi Nakamura(Japan Clinical Cancer Research Organization), Yuichi Shibuya(University of Kochi), Masaki Ueno(Toranomon Hospital), Tetsu Nakamura, Masakazu Takagi(Apple (Israel)), Jun Hihara(Hiroshima City Asa Citizens Hospital)
Cited by 24
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713